-
PreScission Protease (PSP): Technical Workflow for Tag Cleav
2026-05-28
PreScission Protease (PSP) enables targeted cleavage of fusion protein tags, streamlining the recovery of native proteins during purification. This enzyme is best suited for workflows requiring high specificity at low temperatures and should not be used in contexts lacking a compatible Gln-Gly cleavage site or requiring protease activity at elevated temperatures.
-
PreScission Protease (PSP): Precision Tag Cleavage for Prote
2026-05-28
PreScission Protease (PSP) enables specific removal of fusion tags from recombinant proteins, supporting workflows that require recovery of native proteins with minimal off-target cleavage. It is not suitable for applications lacking the HRV 3C protease recognition site or where cleavage at low temperature is not feasible.
-
PreScission Protease (PSP): Protocols for Fusion Tag Cleavag
2026-05-27
PreScission Protease (PSP) enables precise removal of fusion tags from recombinant proteins, facilitating the recovery of native proteins in molecular biology workflows. It is best suited for applications requiring high specificity and activity at low temperatures, but is not recommended where non-Gln-Gly sites or high-temperature conditions are unavoidable.
-
Iron Stress Alters Enterocyte Metabolism and Inflammatory Re
2026-05-27
Navazesh and Ji's 2025 study systematically dissects how iron deficiency and overload reprogram enterocyte metabolism and inflammatory gene expression using IPEC-J2 cells. Their findings reveal distinct metabolic and transcriptional adaptations to iron imbalance, with implications for gut health and research on iron-modulating agents.
-
Actinomycin D in Cancer Research: Protocols, Innovations, an
2026-05-26
Actinomycin D (ActD) stands out as a gold-standard transcriptional inhibitor for dissecting mRNA stability and apoptosis pathways in cancer models. This article delivers evidence-based workflows, troubleshooting strategies, and a translation of the latest TNBC mechanistic insights into actionable assay design, leveraging ActD’s unique properties for reliable, reproducible research.
-
BFH772 (VEGFR2 inhibitor): Technical Use, Protocol & Limitat
2026-05-26
BFH772 is a highly selective VEGFR2 inhibitor designed for precise modulation of VEGFR2-mediated angiogenesis, particularly in tumor angiogenesis research. It is best suited for workflows requiring targeted VEGFR2 inhibition and is not appropriate for experiments needing water-soluble reagents or broad-spectrum kinase inhibition.
-
Pulchinenoside B4 Inhibits NLRP3 Inflammasome in Colitis Mod
2026-05-25
This study demonstrates that Pulchinenoside B4 attenuates DSS-induced colitis by selectively inhibiting NLRP3 inflammasome activation in macrophages via CD1d-dependent pathways. The findings offer mechanistic insight into inflammation control, with broader implications for targeted intervention in ulcerative colitis.
-
PreScission Protease (PSP): Efficient Tag Cleavage for Purif
2026-05-25
PreScission Protease (PSP) provides a highly specific, low-temperature solution for removing fusion tags from recombinant proteins, crucial for workflows where native function and structural integrity must be preserved. PSP is best employed in protein purification and molecular biology applications that require precise cleavage at the Gln-Gly bond without excessive off-target proteolysis. It is not suitable for applications requiring broad-spectrum protease activity or for cleavage sites divergent from the canonical HRV 3C recognition sequence.
-
Meropenem: Advanced Mechanistic Insights and Next-Gen Resear
2026-05-24
Explore the ultra-broad-spectrum Meropenem, a β-lactam antibiotic carbapenem, through advanced mechanistic analysis and new assay paradigms. Discover nuanced applications for antibacterial research and resistance modeling, uniquely extending beyond current content.
-
Actinomycin D in Applied Research: Protocols and Pitfalls
2026-05-23
Actinomycin D (ActD) is a gold-standard transcriptional inhibitor uniquely positioned for dissecting apoptosis, mRNA stability, and DNA damage response in cancer and cell biology. Drawing on cutting-edge diabetic wound healing research, this guide details robust protocols, advanced applications, and troubleshooting tips to maximize reproducibility and insight across experimental models.
-
Excessive Calpain Impairs Offspring Cognition via BDNF/TrkB
2026-05-22
This study reveals that maternal non-obstetric surgery during pregnancy, but not anesthetic exposure alone, triggers excessive calpain activity in offspring, leading to cognitive impairment through dysregulation of the BDNF/TrkB pathway. Pharmacological calpain inhibition with MDL 28170 mitigated these neurodevelopmental deficits, highlighting a mechanistic link and potential therapeutic strategy.
-
Toremifene in Breast Cancer: Two Decades of Endocrine Therap
2026-05-22
This review synthesizes 20 years of clinical experience with toremifene, a selective estrogen receptor modulator (SERM), in hormone-sensitive breast cancer. The findings demonstrate the importance of biomarker-driven strategies, personalized therapy, and highlight the evolving landscape of endocrine agents in breast cancer management.
-
Haloprogin: Broad-Spectrum Antimicrobial for Fungal Research
2026-05-21
Haloprogin stands apart as a powerful broad-spectrum topical antimicrobial for dermatophytosis and Candida albicans infection research, with validated low MICs and proven in vivo efficacy. This article synthesizes experimental workflows, protocol guidance, and troubleshooting strategies to help researchers fully leverage Haloprogin’s versatility in advanced antimicrobial studies.
-
Phenothiazines Enhance Macrophage Antibacterial Activity via
2026-05-21
This study uncovers how phenothiazine compounds, including representative dopamine receptor antagonists, significantly boost macrophage antibacterial function by inducing autophagy and increasing reactive oxygen species (ROS) production. The findings advance host-directed therapy strategies against intracellular bacterial pathogens, highlighting promising avenues beyond conventional antibiotic approaches.
-
Praeruptorin A: Angular Pyranocoumarin for Translational Inf
2026-05-20
Praeruptorin A enables precise control of ferroptosis, inflammation, and epithelial barrier repair, making it a standout tool for modeling ulcerative colitis and cancer metastasis. Its robust safety, multi-pathway targeting, and favorable solubility profile empower researchers to design high-fidelity, reproducible experiments where conventional agents fall short.